Follow @TheHPRA
Contact us
As Gaeilge
My HPRA:
Login
Register
About Us
Medicines
Veterinary
Medical Devices
Cosmetics
Controlled Substances
Blood, Tissues, Organs
Medicines
Safety Notices
My HPRA:
Login
Register
About Us
Medicines
COVID-19 vaccines and treatments
Our Role
Medicines Information
Safety Information
Safety Notices
Quality Information
Regulatory Information
News & Events
Special Topics
Emergency Medicines
Emergency Contact Details
Veterinary
Medical Devices
Cosmetics
Controlled Substances
Blood, Tissues, Organs
Defitelio (defibrotide) - Important Safety Information from Gentium S.r.l. as approved by the HPRA (13.06.2022)
Notice type:
3rd Party Publications
Date:
14/06/2022
Problem Or Issue:
Important Safety Information from Gentium S.r.l. regarding Defitelio (defibrotide): Do not use for prophylaxis of veno-occlusive disease (VOD) after post-hematopoietic stem-cell transplantation (HSCT)
Important Safety Information - Defitelio (defibrotide)
« Back
Date Printed: 28/03/2024